BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33954285)

  • 1. Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors.
    Mamnoon B; Loganathan J; Confeld MI; De Fonseka N; Feng L; Froberg J; Choi Y; Tuvin DM; Sathish V; Mallik S
    ACS Appl Bio Mater; 2021 Feb; 4(2):1450-1460. PubMed ID: 33954285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-Responsive, Polymeric Nanocarriers for Targeted Drug Delivery to Estrogen Receptor-Positive Breast Cancer Cell Spheroids.
    Mamnoon B; Feng L; Froberg J; Choi Y; Sathish V; Mallik S
    Mol Pharm; 2020 Nov; 17(11):4312-4322. PubMed ID: 32926627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-Penetrating, Hypoxia-Responsive Echogenic Polymersomes For Drug Delivery To Solid Tumors.
    Kulkarni P; Haldar MK; Karandish F; Confeld M; Hossain R; Borowicz P; Gange K; Xia L; Sarkar K; Mallik S
    Chemistry; 2018 Aug; 24(48):12490-12494. PubMed ID: 29968262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Estrogen Receptor-Positive Breast Microtumors with Endoxifen-Conjugated, Hypoxia-Sensitive Polymersomes.
    Mamnoon B; Feng L; Froberg J; Choi Y; Sathish V; Taratula O; Taratula O; Mallik S
    ACS Omega; 2021 Oct; 6(42):27654-27667. PubMed ID: 34722965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constructing aptamer anchored nanovesicles for enhanced tumor penetration and cellular uptake of water soluble chemotherapeutics.
    Li X; Zhu X; Qiu L
    Acta Biomater; 2016 Apr; 35():269-79. PubMed ID: 26873366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer.
    Liu M; Ma W; Zhao D; Li J; Li Q; Liu Y; Hao L; Lin Y
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25825-25835. PubMed ID: 34038071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery.
    Thambi T; Deepagan VG; Yoon HY; Han HS; Kim SH; Son S; Jo DG; Ahn CH; Suh YD; Kim K; Kwon IC; Lee DS; Park JH
    Biomaterials; 2014 Feb; 35(5):1735-43. PubMed ID: 24290696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-Responsive Polymersomes for Drug Delivery to Hypoxic Pancreatic Cancer Cells.
    Kulkarni P; Haldar MK; You S; Choi Y; Mallik S
    Biomacromolecules; 2016 Aug; 17(8):2507-13. PubMed ID: 27303825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.
    Simón-Gracia L; Hunt H; Scodeller P; Gaitzsch J; Kotamraju VR; Sugahara KN; Tammik O; Ruoslahti E; Battaglia G; Teesalu T
    Biomaterials; 2016 Oct; 104():247-57. PubMed ID: 27472162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified Bovine Milk Exosomes for Doxorubicin Delivery to Triple-Negative Breast Cancer Cells.
    Pullan J; Dailey K; Bhallamudi S; Feng L; Alhalhooly L; Froberg J; Osborn J; Sarkar K; Molden T; Sathish V; Choi Y; Brooks A; Mallik S
    ACS Appl Bio Mater; 2022 May; 5(5):2163-2175. PubMed ID: 35417133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy.
    Chen J; Yang Q; Liu M; Lin M; Wang T; Zhang Z; Zhong X; Guo N; Lu Y; Xu J; Wang C; Han M; Wei Q
    Int J Nanomedicine; 2019; 14():8161-8177. PubMed ID: 31632025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors.
    Karandish F; Froberg J; Borowicz P; Wilkinson JC; Choi Y; Mallik S
    Colloids Surf B Biointerfaces; 2018 Mar; 163():225-235. PubMed ID: 29304437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
    Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer.
    Paulmurugan R; Bhethanabotla R; Mishra K; Devulapally R; Foygel K; Sekar TV; Ananta JS; Massoud TF; Joy A
    Mol Cancer Ther; 2016 Feb; 15(2):221-31. PubMed ID: 26553061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
    Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleus-Targeted, Echogenic Polymersomes for Delivering a Cancer Stemness Inhibitor to Pancreatic Cancer Cells.
    Karandish F; Mamnoon B; Feng L; Haldar MK; Xia L; Gange KN; You S; Choi Y; Sarkar K; Mallik S
    Biomacromolecules; 2018 Oct; 19(10):4122-4132. PubMed ID: 30169024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeted and stimulus-responsive polymeric prodrug nanoparticles to enhance the anticancer therapeutic efficacy of doxorubicin.
    Kim N; Kwon S; Kwon G; Song N; Jo H; Kim C; Park S; Lee D
    J Control Release; 2024 May; 369():351-362. PubMed ID: 38552963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer.
    Cano-Cortes MV; Navarro-Marchal SA; Ruiz-Blas MP; Diaz-Mochon JJ; Marchal JA; Sanchez-Martin RM
    Nanomedicine; 2020 Feb; 24():102120. PubMed ID: 31676374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.